Case study · Debt refinancing · Health & wellness

Isagenix / Institutional Refinancing

Strategic, product, supply-chain, and market-viability diligence supporting a debt-refinancing mandate involving Cerberus Capital Management, Arbour Lane Capital Management, and Crescent Capital Group.

BoCG Inc.6 min readEnterprise Value Creation Platform
$170MApproximate total debt eliminated
$130MSenior secured debt eliminated
$40MUnsecured debt eliminated

The refinancing context

Isagenix entered a debt-refinancing and recapitalization process that required institutional capital providers to evaluate more than the company’s balance-sheet structure. The durability of the enterprise depended on product relevance, supply-chain capability, market viability, and the operating assumptions supporting the go-forward business.

The completed recapitalization eliminated approximately $170 million of total debt—approximately $130 million of senior secured debt and $40 million of unsecured debt. The founders also contributed approximately $95 million in value through a combination of cash and debt forgiveness.

The mandate involved Cerberus Capital Management, Arbour Lane Capital Management, and Crescent Capital Group. Public transaction materials identify these firms among the investor group associated with the company’s recapitalization.

BoCG’s mandate

BoCG was contracted to provide strategic diligence, product assessment, supply-chain analysis, and market-viability studies in support of the refinancing process.

This placed the work between financial restructuring and operating reality. The objective was to give decision-makers a clearer view of whether the commercial and operating fundamentals could support a sustainable capital structure.

Strategic and market diligence

The strategic work examined competitive positioning, customer dynamics, channel performance, revenue quality, sales productivity, and the market assumptions underpinning the business plan.

Market viability was evaluated as an execution question—not simply a measure of category size. The assessment considered whether the enterprise could translate product demand, customer economics, and channel capability into repeatable operating performance.

Product and supply-chain assessment

The product work considered portfolio relevance, development requirements, and the relationship between product strategy and commercial performance. Supply-chain diligence examined the operating capabilities and dependencies required to support availability, quality, working capital, and scalable delivery.

Connecting these workstreams helped reveal risks that could remain hidden when product, market, and supply-chain questions are evaluated independently.

Recapitalization and decision support

The resulting diligence gave the capital group an integrated view of strategic viability and operating risk alongside the refinancing analysis. The completed transaction materially reduced the company’s debt burden and transitioned majority ownership to the investor group.

BoCG’s role was to strengthen the decision basis through enterprise-level diligence. The profile does not imply that BoCG structured the debt, independently produced the approximately $170 million reduction, controlled the recapitalization, or was responsible for the company’s subsequent performance.

Attribution note: Cerberus Capital Management, Arbour Lane Capital Management, and Crescent Capital Group are identified as counterparties to BoCG’s diligence mandate. Public recapitalization materials identify additional participants; this profile does not purport to list the complete investor group.

Have an opportunity where execution can materially change enterprise value?

Start with BoCG